NHS Trust Walks Away From Folkestone and Deal Urgent Treatment Centres Over Contracts That Couldn’t Break Even — But Who Takes Over?
shepwayvox
The NHS has been planning to hand over Folkestone and Deal’s urgent treatment centres for some time. The contracts expire next March, the services are promised to continue, and the financial problems behind Kent and Medway’s wider healthcare shake-up are hardly a secret. Yet one important question remains unanswered. Who will actually be running them?
Come the morning of 1 April 2027, patients arriving at the Royal Victoria Hospital in Folkestone or Victoria Hospital in Deal should find their urgent treatment centres operating as usual.
That’s the promise from NHS Kent and Medway Integrated Care Board (ICB).
The organisation currently responsible for both centres, Kent Community Health NHS Foundation Trust (KCHFT), is stepping away when its contracts expire on 31 March. Alternative providers are to be appointed, with services continuing through the handover. This is a planned change of contractor, not an announced closure.
And these are hardly services the public can afford to lose.
Over the preceding twelve months, the picture was much the same. Both centres were almost at capacity, according to the trust, although it didn’t explain precisely how those percentages were calculated.
So why change the provider?
The answer goes back further than the approaching contract deadline.
In July 2025, senior NHS officials were already explaining to Kent County Council why urgent treatment services across Kent needed overhauling.
There were different providers, different opening hours and different ways of assessing patients. In some places, people were being assessed twice before receiving treatment.
But behind the reorganisation lay another problem.
Money.
NHS Kent and Medway had been facing an extremely high-risk financial position. Its efforts to achieve financial balance were considered undeliverable on the existing trajectory, making longer-term changes increasingly important.
This wasn’t a problem that appeared overnight.
The November 2026 board papers show an ICB formally in financial turnaround, forecasting a £50.8 million deficit for 2026/27 despite planning almost £49.7 million in savings.
Its financial sustainability risk remains outside the Board’s accepted risk tolerance.
That financial backdrop helps explain the pressure to reorganise services. It doesn’t, by itself, prove that KCHFT relinquished these particular contracts because of the ICB’s deficit.
The trust’s publicly stated reason is that it wants to concentrate on providing community healthcare.
It has already handed over urgent treatment services in Sevenoaks, Gravesend, Sittingbourne and Sheppey. Medway followed on 28 September 2026, with Medway NHS Foundation Trust assuming responsibility.
In other words, Folkestone and Deal are part of an established programme of handovers.
The Shepway Vox Team has written to ICB Chief Executive Adam Doyle and KCHFT Chief Executive Mairead McCormick asking about the decision to relinquish the contracts and the arrangements for transferring services. At the time of publication, no response had been received.
There is, however, another company in the picture.
Although KCHFT holds the main contracts, it doesn’t provide all the clinical services itself.
In March 2025, a government procurement notice identified Channel Health Alliance Limited as the recipient of a clinical-services subcontract covering Folkestone and Deal.
The published value was £3,389,952. This represented an extension of an existing arrangement rather than a fresh open competition. The figure is the published contract value, not necessarily the amount paid.
Channel Health Alliance already helps deliver GP-led clinical services at both centres.
So what happens to that arrangement when KCHFT leaves?
Will the company continue working under whoever takes over? Will another NHS trust assume responsibility, as happened in Medway? Or will a completely different provider be appointed?
Nobody has publicly confirmed the answer.
The November 2026 ICB papers and declarations register also records that board member Dr Jonathan Bryant holds a minority shareholding of less than 5% in Channel Health Alliance. The interest is declared. Any relevant commissioning decision involving the company would need appropriate conflict-of-interest safeguards. There is no evidence in the papers that Dr Bryant has improperly participated in such a decision.
The Shepway Vox Team has searched the publicly available procurement and contract-award notices. As of 19 November 2026, we haven’t identified a tender or contract award specifically naming the replacement providers for Folkestone and Deal.
That doesn’t mean the ICB hasn’t been arranging the handover.
Under the NHS Provider Selection Regime, healthcare contracts don’t always require an open competition. A replacement can be selected through other permitted processes, subject to the relevant rules and transparency requirements.
But residents have yet to be told which route is being followed.
And there’s a further development.
Buried in the ICB papers for its forthcoming 24 November meeting is a proposal that could eventually change how urgent healthcare operates in Folkestone.
The town is being considered as a proof-of-concept site for a redesigned urgent-care service.
The idea is to bring urgent treatment, GP out-of-hours services and neighbourhood healthcare closer together. The ICB hopes to decide on its preferred model by 31 March 2027, with initial changes potentially following by September.
The Folkestone proposal remains conditional. Its national pilot status and local approval requirements haven’t been confirmed, while the financial and workforce implications of the wider urgent-care changes are still being assessed.
That makes the timing interesting.
The current contracts expire on the very day the ICB hopes to decide its future model.
It doesn’t mean patients will face a gap in treatment. The NHS has promised continuity through the transfer to new contractors. Nor does it mean the existing Royal Victoria Hospital service will necessarily change when a new provider arrives.
But it leaves questions about which organisation will operate the centre and what the longer-term model will look like.
For Deal, the uncertainty is different. The November papers identify Folkestone as a possible pilot location but don’t set out an equivalent site-specific proposal for Deal.
And Deal has experienced difficulties with another KCHFT handover before.
In January 2025, Kent councillors examined the earlier withdrawal of the walk-in blood-testing service at Deal Hospital. The ICB acknowledged that two attempts to procure replacement provision had failed, with alternative arrangements subsequently expanded through local GP surgeries.
Blood testing isn’t urgent treatment. But the experience demonstrates why a promised replacement needs to be backed by workable arrangements.
The good news is that Folkestone and Deal’s urgent treatment centres aren’t being shut down. The departure of KCHFT has been planned over a substantial period, and the NHS has committed to maintaining care during the handover.
The unanswered question isn’t whether somebody might eventually take over. It’s who, under what arrangements, and when the public will be told.
After all, the NHS has had time to prepare.
Patients shouldn’t need to understand procurement rules, provider alliances or financial recovery plans to use their local urgent treatment centre.
They simply need it to be there when they need it.
The NHS has promised that the doors will stay open on 1 April 2027. Now it needs to tell Folkestone and Deal whose name will be on the contract, and who’ll be there to treat the patients walking through those doors.